Save your place

Sign in to WhoBought

Please try again later.

Insmed Incorporated (INSM) institutional ownership

Latest close $104.73 Jul 27, 2026
Market cap$34.2B 52-week range SectorHealthcare
Funds holding · Q1 2026
675
reported INSM position changes
Top owners · Q1 2026
JPMorgan Chase & Co
Darwin Global Management, Ltd.
FMR LLC
Institutional activity · Q1 2026
Net bought $510M
374 buyers · 301 sellers

Insmed Incorporated (INSM) price and institutional activity

Dates

Q1 2026

$3.9B bought by 374 investors
FMR LLC$497MArtisan Partners Limited Partnership$259M +372 more
$3.4B sold by 301 investors
Darwin Global Management, Ltd.-$635MNorges-$448M +299 more
Bought Sold Totals per quarter; hover a bar for the names.

Insmed Incorporated (INSM) ownership

Largest disclosed holders in Q1 2026.

13F filing season in progress; institutional ownership uses the last closed quarter (2026 Q1)

JPMorgan Chase & Co

owns 11.1% of shares outstanding
Est. $3.9B · Shares: 24.1M

Darwin Global Management, Ltd.

owns 7.8% of shares outstanding
Est. $2.7B · Shares: 16.8M

FMR LLC

owns 6.1% of shares outstanding
Est. $2.2B · Shares: 13.2M

Baker Bros. Advisors LP

owns 3.4% of shares outstanding
Est. $1.2B · Shares: 7.4M

Artisan Partners Limited Partnership

owns 3.0% of shares outstanding
Est. $1.1B · Shares: 6.5M

D. E. Shaw & Co., Inc.

owns 2.6% of shares outstanding
Est. $920M · Shares: 5.6M

Capital International Investors

owns 2.6% of shares outstanding
Est. $915M · Shares: 5.6M

Rtw Investments, LP

owns 2.2% of shares outstanding
Est. $792M · Shares: 4.8M

Insmed Incorporated (INSM) institutional activity · 675

Investor Type Est. change Change Δ Own Date
Darwin Global Management, Ltd. · Reduced −$635M
Change −4.1M Date Q1 2026
Darwin Global Management, Ltd. Reduced· Q1 2026 −$635M −4.1M Q1 2026
FMR LLC · Added +$497M
Change +3.2M Δ Own +32.6% Date Q1 2026
FMR LLC Added· Q1 2026 +$497M +3.2M +32.6% Q1 2026
Norges · Exited −$448M
Change −2.9M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$448M −2.9M −100.0% Q1 2026
Orbis Allan Gray Ltd · Reduced −$355M
Change −2.3M Date Q1 2026
Orbis Allan Gray Ltd Reduced· Q1 2026 −$355M −2.3M Q1 2026
Artisan Partners Limited Partnership · Added +$259M
Change +1.7M Date Q1 2026
Artisan Partners Limited Partnership Added· Q1 2026 +$259M +1.7M Q1 2026
BlackRock · Added +$248M
Change +1.6M Date Q1 2026
BlackRock Added· Q1 2026 +$248M +1.6M Q1 2026
Capital World Investors · New +$209M
Change +1.4M Date Q1 2026
Capital World Investors New· Q1 2026 +$209M +1.4M Q1 2026
D. E. Shaw & Co., Inc. · Added +$196M
Change +1.3M Δ Own +29.3% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +$196M +1.3M +29.3% Q1 2026
Paradigm Biocapital Advisors LP · New +$193M
Change +1.3M Date Q1 2026
Paradigm Biocapital Advisors LP New· Q1 2026 +$193M +1.3M Q1 2026
Ameriprise Financial Inc · Added +$167M
Change +1.1M Date Q1 2026
Ameriprise Financial Inc Added· Q1 2026 +$167M +1.1M Q1 2026
Westfield Capital Management Co LP · Added +$159M
Change +1.0M Date Q1 2026
Westfield Capital Management Co LP Added· Q1 2026 +$159M +1.0M Q1 2026
Citadel Advisors LLC Added· Q1 2026 +$158M +1.0M +88.6% Q1 2026
JPMorgan Chase & Co · Added +$146M
Change +951K Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$146M +951K Q1 2026
T. Rowe Price Associates · Reduced −$146M
Change −947K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −$146M −947K Q1 2026
Jefferies Financial Group Inc. · Reduced −$142M
Change −923K Date Q1 2026
Jefferies Financial Group Inc. Reduced· Q1 2026 −$142M −923K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 675

Famous investor activity in Insmed Incorporated (INSM)

Insmed Incorporated (INSM) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lewis William · Director 2 operations −$1.1M
Price $105.62–$106.43 Qty −11K Owned 259K ΔOwn −4.0% Trade date Jul 23, 2026 Filed date Jul 24, 2026
Lewis William Director 2 operations $105.62–$106.43 −11K −$1.1M 259K −4.0% Jul 23, 2026 Jul 24, 2026
Lewis William · Director 4 operations 0
Price $17.16–$30.46 Owned 0 Trade date Jul 23, 2026 Filed date Jul 24, 2026
Lewis William Director 4 operations $17.16–$30.46 0 0 Jul 23, 2026 Jul 24, 2026
Lewis William · Director 3 operations −$1.3M
Price $116.55–$118.52 Qty −11K Owned 259K ΔOwn −4.0% Trade date Jul 9, 2026 Filed date Jul 10, 2026
Lewis William Director 3 operations $116.55–$118.52 −11K −$1.3M 259K −4.0% Jul 9, 2026 Jul 10, 2026
Lewis William · Director 4 operations 0
Price $17.16–$30.46 Owned 4K Trade date Jul 9, 2026 Filed date Jul 10, 2026
Lewis William Director 4 operations $17.16–$30.46 0 4K Jul 9, 2026 Jul 10, 2026
Flammer Martina M.d. · Officer 2 operations −$1.4M
Price $109.02–$110.60 Qty −12K Owned 60K ΔOwn −16.9% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Flammer Martina M.d. Officer 2 operations $109.02–$110.60 −12K −$1.4M 60K −16.9% Jul 6, 2026 Jul 8, 2026
Flammer Martina M.d. · Officer 4 operations 0
Price $19.74–$29.13 Owned 4K Trade date Jul 6, 2026 Filed date Jul 8, 2026
Flammer Martina M.d. Officer 4 operations $19.74–$29.13 0 4K Jul 6, 2026 Jul 8, 2026
Lewis William · Director 5 operations −$2.2M
Price $102.34–$106.27 Qty −21K Owned 259K ΔOwn −7.6% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Lewis William Director 5 operations $102.34–$106.27 −21K −$2.2M 259K −7.6% Jun 25, 2026 Jun 26, 2026
Lewis William · Director 4 operations 0
Price $17.16–$30.46 Owned 9K Trade date Jun 25, 2026 Filed date Jun 26, 2026
Lewis William Director 4 operations $17.16–$30.46 0 9K Jun 25, 2026 Jun 26, 2026
Butera Samuele · Officer 2 operations 20K
Owned 13K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Butera Samuele Officer 2 operations 20K 13K Jun 23, 2026 Jun 24, 2026
Smith Michael Alexander · Officer Sell −$173K
Price $95.82 Qty −2K Owned 38K ΔOwn −4.6% Trade date Jun 22, 2026 Filed date Jun 24, 2026
Smith Michael Alexander Officer Sell $95.82 −2K −$173K 38K −4.6% Jun 22, 2026 Jun 24, 2026
Lewis William · Director Sell −$613K
Price $94.03 Qty −7K Owned 259K Trade date Jun 8, 2026 Filed date Jun 10, 2026
Lewis William Director Sell $94.03 −7K −$613K 259K Jun 8, 2026 Jun 10, 2026
Flammer Martina M.d. · Officer Sell −$193K
Price $103.78 Qty −2K Owned 60K Trade date Jun 5, 2026 Filed date Jun 5, 2026
Flammer Martina M.d. Officer Sell $103.78 −2K −$193K 60K Jun 5, 2026 Jun 5, 2026
Adsett Roger · Officer Sell −$242K
Price $102.27 Qty −2K Owned 99K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Adsett Roger Officer Sell $102.27 −2K −$242K 99K Jun 3, 2026 Jun 5, 2026
Bonstein Sara · CFO Sell −$246K
Price $102.27 Qty −2K Owned 69K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Bonstein Sara CFO Sell $102.27 −2K −$246K 69K Jun 3, 2026 Jun 5, 2026
Smith Michael Alexander · Officer Sell −$221K
Price $102.27 Qty −2K Owned 39K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Smith Michael Alexander Officer Sell $102.27 −2K −$221K 39K Jun 3, 2026 Jun 5, 2026
15 of 88
15 of 88 Sign in to continue to older insider transactions.

Insmed Incorporated (INSM) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 14.1M
% of shares outstanding 9.9% Filing date Feb 13, 2024
Vanguard Group Inc 14.1M 9.9% Feb 13, 2024
BlackRock Inc. 11.5M
% of shares outstanding 8.0% Filing date Jan 25, 2024
BlackRock Inc. 11.5M 8.0% Jan 25, 2024
Darwin Global Management, Ltd. 16.8M
% of shares outstanding 7.8% Filing date May 15, 2026
Darwin Global Management, Ltd. 16.8M 7.8% May 15, 2026
T. Rowe Price Associates 12.6M
% of shares outstanding 7.3% Filing date Nov 14, 2024
T. Rowe Price Associates 12.6M 7.3% Nov 14, 2024
FMR LLC 13.1M
% of shares outstanding 6.1% Filing date May 6, 2026
FMR LLC 13.1M 6.1% May 6, 2026
Vanguard Capital Management 11.5M
% of shares outstanding 5.3% Filing date Apr 30, 2026
Vanguard Capital Management 11.5M 5.3% Apr 30, 2026
JPMorgan Chase & Co. 10.4M
% of shares outstanding 4.7% Filing date Jul 22, 2026
JPMorgan Chase & Co. 10.4M 4.7% Jul 22, 2026
Palo Alto Investors LP 5.9M
% of shares outstanding 4.3% Filing date Feb 14, 2023
Palo Alto Investors LP 5.9M 4.3% Feb 14, 2023
8 of 11

Insmed Incorporated (INSM) ownership FAQ

Who owns INSM?

675 reporting institutions disclosed INSM position changes in the Q1 2026 snapshot. The largest disclosed owners include JPMorgan Chase & Co, Darwin Global Management, Ltd., FMR LLC. WhoBought does not publish a total institutional-ownership percentage for INSM: aggregate 13F filings can report the same shares more than once (a parent manager and its subsidiary filers, or shares out on loan), so a summed percentage would overstate what institutions really hold.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.